Skip to content
TrialScanner

NCT06431256

Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD

Phase 3TerminatedCOLLCollaborator

Registry record

Lead sponsor
Ironshore Pharmaceuticals and Development, Inc
Conditions
Attention Deficit Hyperactivity Disorder
Primary completion
Jul 11, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06431256 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06431256: Efficacy, Safety & Pharmacoki... | TrialScanner